FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Tong Zhijun 		2. Issuer Name and Ticker or Trading Symbol

China Biologic Products, Inc. [ CBPO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

18TH FLOOR, JIALONG I NTERNATIONAL, BUILDING, 19 CHAOYANG PARK ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/4/2015
(Street)

BEIJING, F4 100125
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock   12/4/2015     M (1)    486   (1) A $9.85   14486   D    
Common stock   12/4/2015     S (1)    486   (1) D $119.00   14000   D    
Common stock   12/4/2015     M (2)    10000   (2) A $9.61   24000   D    
Common stock   12/4/2015     S (2)    10000   (2) D $118.00   14000   D    
Common stock   12/7/2015     M (3)    4514   (3) A $9.85   18514   D    
Common stock   12/7/2015     S (3)    4514   (3) D $119.00   14000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (4) $9.85   12/4/2015     M         486    9/1/2013   8/31/2022   Common stock   486     (4) 24514   (6) D    
Stock Option (right to buy)   (5) $9.61   12/4/2015     M         10000    10/21/2012   4/20/2022   Common stock   10000     (5) 14514   (6) D    
Stock Option (right to buy)   (4) $9.85   12/7/2015     M         4514    9/1/2013   8/31/2022   Common stock   4514     (4) 10000   (6) D    

Explanation of Responses:
( 1)  Represents 486 shares of common stock sold on the open market for $119.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
( 2)  Represents 10,000 shares of common stock sold on the open market for $118.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 5 below for further details on the relevant stock options.
( 3)  Represents 4,514 shares of common stock sold on the open market for $119.00 per share on December 7, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
( 4)  Represents previously reported ten year non-qualified stock options to purchase 5,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options vested on September 1, 2013.
( 5)  Represents previously reported stock options to purchase 20,000 shares of the Issuer's common stock, granted pursuant to a stock option agreement dated April 20, 2012. The options vested in two equal tranches on October 21, 2012 and April 21, 2013.
( 6)  Includes the balance of the previously reported stock options as disclosed in Footnotes 4 and 5 above.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Tong Zhijun
18TH FLOOR, JIALONG I NTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING, F4 100125 		X



Signatures
/s/ Zhijun Tong 12/8/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more China Bioligic Products Charts.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more China Bioligic Products Charts.